Cover Image

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases

Saved in:

Bibliographic Details
Main Authors:	van der Klis F (Author), Berbers G (Author), Tacke C (Author), Scherpenisse M (Author), Groot N (Author), Heijstek MW (Author), Wulffraat NM (Author)
Format:	Book
Published:	BMC, 2011-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
by: Heijstek MW, et al.
Published: (2008)

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study
by: Ingrid Herta Rotstein Grein, et al.
Published: (2020)

Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations
by: Marc H. Jansen, et al.
Published: (2022)

Validation of the juvenile artritis disease activity score in 1124 patient visits
by: Wulffaat NM, et al.
Published: (2011)

Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis
by: Heijstek MW, et al.
Published: (2008)

Immunogenicity and safety of vaccination in children with paediatric rheumatic diseases: a scoping review
by: Jacqueline Cunninghame, et al.
Published: (2023)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
by: Suzanne M. Garland, et al.
Published: (2022)

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.
by: Adriana Coracini Tonacio, et al.
Published: (2021)

A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus
by: Edison J. Mavundza, et al.
Published: (2020)

The effect of perceived psychological stress on the immunogenicity of the quadrivalent human papillomavirus vaccine in males
by: Rebecca F. Wu, et al.
Published: (2017)

Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection
by: Maria Zurek Munk-Madsen, et al.
Published: (2018)

Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals
by: Xiao-Juan Yu, et al.
Published: (2020)

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study
by: Huiqiong Zeng, et al.
Published: (2022)

Human papillomavirus vaccination: evidence base for efficacy and safety
by: Yuliya E. Dobrokhotova, et al.
Published: (2021)

Long-term efficacy and safety of human papillomavirus vaccination
by: De Vincenzo R, et al.
Published: (2014)

Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge
by: J. Hoes, et al.
Published: (2022)

Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay
by: M. S. Camacho-Lovillo, et al.
Published: (2017)

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial
by: Vu Dinh Thiem, et al.
Published: (2021)

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial
by: Deborah Watson-Jones, ProfPhD, et al.
Published: (2022)

Immunogenicity, safety and tolerability of intradermal influenza vaccines
by: Ivan F. N. Hung, et al.
Published: (2018)

Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan
by: Mira Namba, et al.
Published: (2023)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
by: Maria E. Sundaram, et al.
Published: (2022)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
by: Eva Hong, et al.
Published: (2017)

Incarcerated Adolescents' Attitudes Toward Human Papillomavirus Vaccine: Report From a Juvenile Facility in Kansas
by: Molly Allison MPH, et al.
Published: (2019)

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20-45 years of age
by: Tianmeng Wen, et al.
Published: (2024)

Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics
by: Maureen Sanderson, et al.
Published: (2017)

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial
by: Zhao-Jun Mo, et al.
Published: (2022)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011)

Human Papillomavirus Vaccine: A New Opportunity for The Treatment of Human Papillomavirus Infections
by: Sneha Ambwani, et al.
Published: (2014)

Characterization of the UK anthrax vaccine and human immunogenicity
by: Tapasvi Modi, et al.
Published: (2021)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
by: Pluijm Saskia M F, et al.
Published: (2011)

Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study
by: Milou Ohm, et al.
Published: (2023)

Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
by: Ainur Nurpeisova, et al.
Published: (2022)

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
by: Osamu Matsuoka, et al.
Published: (2018)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010)

A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines
by: Rasha Ashmawy, et al.
Published: (2022)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010)

Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine
by: Eddie Underwood, et al.
Published: (2023)

Human Papillomavirus and Vaccination in Cervical Cancer
by: Kung-Liahng Wang
Published: (2007)

Human papillomavirus vaccination for adult women
by: Cecília Maria Roteli-Martins, et al.
Published: (2022)